- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 43.241 ↓ -0.15%
[as on 5 December, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Mirae Asset Healthcare Fund Direct Growth | -1.54% | -0.15% | -0.36% | -0.74% | 0.3% | 1.97% | 22.26% | 17.91% | 22.68% | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.31% |
0.01% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.68% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Quantity | Qty change % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.01% | 2004418 | - |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.88% | 371682 | -1.33% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.41% | 956043 | -3.04% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.21% | 228046 | -1.72% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.42% | 1018081 | -8.12% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 5.07% | 729170 | - |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 4.33% | 1193084 | - |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.09% | 1012443 | -8.17% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.02% | 946480 | - |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.77% | 1475624 | - |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.56% | 790212 | +9.72% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.48% | 1448593 | -3.34% |
| Eris Lifesciences Ltd. | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 3.20% | 567024 | +8.17% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.19% | 163396 | +14.75% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.81% | 830748 | +10.66% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.77% | 1037917 | - |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.72% | 215716 | - |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 2.70% | 411531 | - |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.68% | 448848 | - |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.56% | 786462 | - |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.61% | 235103 | - |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.55% | 183441 | - |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.32% | 526318 | - |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.28% | 281374 | -17.58% |
| Rubicon Research Ltd. | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 0.82% | 372780 | - |
| Deepak Nitrite Ltd. | DEEPAKNTR (INE288B01029) | Chemicals & Petrochemicals | 0.76% | 124170 | - |
| Sagility Ltd. | SAGILITY (INE0W2G01015) | IT - Services | 0.59% | 3159520 | -39.93% |
| Neogen Chemicals Ltd. | NEOGEN (INE136S01016) | Chemicals & Petrochemicals | 0.53% | 102961 | - |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.52% | 227181 | - |
| Laxmi Dental Ltd. | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.45% | 407121 | - |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.01% | 5001 | -99.33% |
Debt
| Name | Rating | Weight % |
|---|
| Mirae Asset Liquid Fund-Direct Plan-Growth | | 0.01% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
Mirae Asset Healthcare Fund Direct Growth - 30 days NAV history
| Date | NAV |
|---|
| 5 December, 2025 | 43.241 |
| 4 December, 2025 | 43.308 |
| 3 December, 2025 | 43.144 |
| 2 December, 2025 | 43.206 |
| 1 December, 2025 | 43.171 |
| 28 November, 2025 | 43.399 |
| 27 November, 2025 | 43.229 |
| 26 November, 2025 | 43.304 |
| 25 November, 2025 | 42.867 |
| 24 November, 2025 | 42.782 |
| 21 November, 2025 | 42.897 |
| 20 November, 2025 | 43.215 |
| 19 November, 2025 | 43.135 |
| 18 November, 2025 | 43.211 |
| 17 November, 2025 | 43.626 |
| 14 November, 2025 | 43.495 |
| 13 November, 2025 | 43.206 |
| 12 November, 2025 | 43.348 |
| 11 November, 2025 | 43.088 |
| 10 November, 2025 | 43.352 |
| 7 November, 2025 | 43.129 |
| 6 November, 2025 | 43.325 |
| 4 November, 2025 | 43.563 |
| 3 November, 2025 | 43.839 |
| 31 October, 2025 | 43.334 |
| 30 October, 2025 | 43.616 |
| 29 October, 2025 | 43.729 |
| 28 October, 2025 | 43.517 |
| 27 October, 2025 | 43.509 |
| 24 October, 2025 | 43.582 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 43.241 as on 5 December, 2025.
What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are -1.54% as on 5 December, 2025.
What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 1.97% as on 5 December, 2025.
What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 22.26% as on 5 December, 2025.
What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 17.91% as on 5 December, 2025.
